| [1] | Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma)[J]. Mayo Clin Proc, 1995,70(11):1068⁃1076. doi: 10.4065/70.11.1068. | 
																													
																						| [2] | Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study[J]. Rheumatology (Oxford), 2006,45(5):614⁃620. doi: 10.1093/rheumatology/kei251. | 
																													
																						| [3] | Kreuter A, Krieg T, Worm M, et al. German guidelines for the diagnosis and therapy of localized scleroderma[J]. J Dtsch Dermatol Ges, 2016,14(2):199⁃216. doi: 10.1111/ddg.12724. | 
																													
																						| [4] | Röcken M, Ghoreschi K. Morphea and lichen sclerosus[M]// Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. USA: Elsevier, 2018:707⁃721. | 
																													
																						| [5] | Goodfield MJD, Jones SK, Veale DJ. The ′connective tissue diseases′[M]// Burns T, Breathnach S, Cox N, Griffiths C. Rook′s textbook of dermatology. 8th ed. Hoboken: Wiley⁃Blackwell, 2010:51,64⁃87. | 
																													
																						| [6] | James WD, Berger TG, Elston DK. Connective tissue diseases[M]// James WD, Berger TG, Elston DK. Andrews′ diseases of the skin: clinical dermatology. 12th ed. Philadelphia: Saunders Elsevier, 2019:167⁃178. | 
																													
																						| [7] | Kencka D, Blaszczyk M, Jabłońska S. Atrophoderma Pasini⁃Pierini is a primary atrophic abortive morphea[J]. Dermatology, 1995,190(3):203⁃206. doi: 10.1159/000246685. | 
																													
																						| [8] | Kellet CV, Orteu CH, Dutz JP. Localized scleroderma[M]// Hertl M. Autoimmune diseases of the skin: pathogenesis, diagnosis, management. 3rd ed. New York: Springer Wien New York, 2011:137⁃172. | 
																													
																						| [9] | 李明. 硬斑病[M]//赵辨. 中国临床皮肤病学. 2版. 南京: 江苏凤凰科学技术出版社, 2017:878⁃885. | 
																													
																						| [10] | 李峰, 李明, 朱小华, 等. 免疫性结缔组织病[M]//王侠生, 徐金华, 张学军. 现代皮肤病学. 2版. 上海: 上海大学出版社, 2020:730⁃799. | 
																													
																						| [11] | Daoud MS, Su WP, Leiferman KM, et al. Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases[J]. J Am Acad Dermatol, 1994,30(6):937⁃943. doi: 10.1016/s0190⁃9622(94)70113⁃x. | 
																													
																						| [12] | Su WP, Greene SL. Bullous morphea profunda[J]. Am J Dermatopathol, 1986,8(2):144⁃147. doi: 10.1097/00000372⁃198604000⁃00009. | 
																													
																						| [13] | 樊雪, 朱晨雨, 毛笑非, 等. 局限性硬皮病522例临床分析[J]. 临床皮肤科杂志, 2016,45(1):5⁃10. doi: 10.16761/j.cnki.1000⁃4963.2016.01.003. | 
																													
																						| [14] | 周海燕, 唐鹤菡, 陈冲, 等. 线状硬斑病107例临床及影像学特点回顾性分析[J]. 中华皮肤科杂志, 2021,54(9):798⁃803. doi: 10.35541/cjd.20201056. | 
																													
																						| [15] | Skrzypek⁃Salamon A, Lis⁃Święty A, Ranosz⁃Janicka I, et al. Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) adapted for use in adult patients: report from an initial validation study[J]. Health Qual Life Outcomes, 2018,16(1):185. doi: 10.1186/s12955⁃018⁃1010⁃z. | 
																													
																						| [16] | Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993[J]. J Rheumatol, 1997,24(1):73⁃80. | 
																													
																						| [17] | Vieira⁃Damiani G, Lage D, Christofoletti DPÉ, et al. Idiopathic atrophoderma of Pasini and Pierini: a case study of collagen and elastin texture by multiphoton microscopy[J]. J Am Acad Dermatol, 2017,77(5):930⁃937. doi: 10.1016/j.jaad.2017.02.044. | 
																													
																						| [18] | Jablonska S, Szczepanski A. Atrophoderma Pasini⁃Pierini: is it an entity?[J]. Dermatologica, 1962,125:226⁃242. | 
																													
																						| [19] | Amano H, Nagai Y, Ishikawa O. Multiple morphea coexistent with atrophoderma of Pasini⁃Pierini (APP): APP could be abortive morphea[J]. J Eur Acad Dermatol Venereol, 2007,21(9):1254⁃1256. doi: 10.1111/j.1468⁃3083.2006.02131.x. | 
																													
																						| [20] | Jablonska S, Blaszczyk M. Is superficial morphea synonymous with atrophoderma Pasini⁃Pierini?[J]. J Am Acad Dermatol, 2004,50(6):979⁃980; author reply 980. doi: 10.1016/j.jaad.2003. 11.088. | 
																													
																						| [21] | Toledano C, Rabhi S, Kettaneh A, et al. Localized scleroderma: a series of 52 patients[J]. Eur J Intern Med, 2009,20(3):331⁃336. doi: 10.1016/j.ejim.2008.07.011. | 
																													
																						| [22] | Ang GC, Lee JB. Linear atrophoderma of Moulin: is it a single disease?[J]. J Am Acad Dermatol, 2005,52(5):923⁃924; author reply 924⁃925. doi: 10.1016/j.jaad.2004.09.043. | 
																													
																						| [23] | Moss C, Shahidullah H. Naevi and other developmental defects[M]//Burns T, Breathnach S, Cox N, et al. Rook′s textbook of dermatology. 8th ed. Hoboken: Wiley⁃Blackwell, 2010:18.1. | 
																													
																						| [24] | Jablonska S. Facial hemiatrophy and its relation to localized scleroderma[M]//Jablonska S. Scleroderma and pseudosclero⁃derma. Poland: PZWL, 1975:537⁃548. | 
																													
																						| [25] | Diaz⁃Perez JL, Connolly SM, Winkelmann RK. Disabling pansclerotic morphea of children[J]. Arch Dermatol, 1980,116(2):169⁃173. | 
																													
																						| [26] | Devidayal, Singh S, Kumar L, et al. Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association[J]. Rheumatol Int, 2002,21(4):158⁃160. doi: 10.1007/s00296⁃001⁃0150⁃2. | 
																													
																						| [27] | 张韡, 陈浩, 徐秀莲, 等. 致残性全硬化性硬斑病六例临床病理特点分析[J]. 中华皮肤科杂志, 2018,51(8):561⁃563. doi: 10.3760/cma.j.issn.0412⁃4030.2018.08.001. | 
																													
																						| [28] | Khatri S, Torok KS, Mirizio E, et al. Autoantibodies in morphea: an update[J]. Front Immunol, 2019,10:1487. doi: 10.3389/fimmu.2019.01487. | 
																													
																						| [29] | Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease[J]. Arthritis Rheum, 2005,52(9):2873⁃2881. doi: 10.1002/art.21264. | 
																													
																						| [30] | Kreuter A, Wischnewski J, Terras S, et al. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center[J]. J Am Acad Dermatol, 2012,67(6):1157⁃1162. doi: 10.1016/j.jaad.2012.04.003. | 
																													
																						| [31] | Lutz V, Francès C, Bessis D, et al. High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea[J]. Arch Dermatol, 2012,148(1):24⁃28. doi: 10.1001/archdermatol.2011.305. | 
																													
																						| [32] | Vanhaecke A, De Schepper S, Paolino S, et al. Coexistence of systemic and localized scleroderma: a systematic literature review and observational cohort study[J]. Rheumatology (Oxford), 2020,59(10):2725⁃2733. doi: 10.1093/rheumatology/keaa297. | 
																													
																						| [33] | Lis⁃Święty A, Skrzypek⁃Salamon A, Ranosz⁃Janicka I, et al. Localized scleroderma: clinical and epidemiological features with emphasis on adulthood⁃versus childhood⁃onset disease differences[J]. J Eur Acad Dermatol Venereol, 2017,31(10):1595⁃1603. doi: 10.1111/jdv.14197. |